Verapamil Hydrochloride
- Product NDC
- 51754-0205
- 11-digit product format
- 517540205
- Labeler code
- 51754
- Product ID
- 51754-0205_d053ac54-7922-4e79-a5a2-62eb3c2c3f4d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- EXELA PHARMA SCIENCES, LLC
- Application
- NDA018925
- Marketing category
- NDA
- Marketing start
- 2018-06-11
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51754-0205-2 | Verapamil Hydrochloride | 4 mL in 1 VIAL | INJECTION | 4 | | 6 |
| 51754-0205-2 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION | 5 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51754-0205 | VERAPAMIL HYDROCHLORIDE INJECTION [EXELA PHARMA SCIENCES, LLC] | 6 | Legacy NDC, 2 package rows | 20210916_eff5e83b-f819-4a5b-9746-12bce328d7a7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51754-0205-2 | 51754020502 | 5 VIAL in 1 CARTON (51754-0205-2) > 4 mL in 1 VIAL | 5 vial | 2018-06-11 | 0000-00-00 | No | No | Current |